From the Guidelines
Urethral candidiasis should be treated with oral fluconazole at a dosage of 200 mg daily for 2 weeks for symptomatic cystitis due to a fluconazole-susceptible Candida species. This recommendation is based on the clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America 1.
Key Considerations
- The treatment approach may vary depending on the severity of the infection and the susceptibility of the Candida species to fluconazole.
- For fluconazole-resistant organisms, alternative treatments such as AmB-d or oral flucytosine may be considered 1.
- It is essential to note that the treatment guidelines provided are for symptomatic candiduria, and the approach may differ for other types of candidiasis.
Treatment Options
- Oral fluconazole: 200 mg daily for 2 weeks for fluconazole-susceptible Candida species 1.
- AmB-d: 0.3–0.6 mg/kg daily for 1–7 days or oral flucytosine: 25 mg/kg 4 times daily for 7–10 days for fluconazole-resistant organisms 1.
- AmB-d bladder irrigation: may be useful for treatment of patients with fluconazole-resistant Candida species, especially C. glabrata 1.
From the FDA Drug Label
Urinary tract infections and peritonitis: For the treatment of Candida urinary tract infections and peritonitis, daily doses of 50 to 200 mg have been used in open, noncomparative studies of small numbers of patients.
The treatment for urethral candida is not explicitly stated, but Candida urinary tract infections can be treated with fluconazole at a daily dose of 50 to 200 mg 2. However, this information does not directly address urethral candida, and therefore, no conclusion can be drawn about the specific treatment for urethral candida.
From the Research
Treatment Options for Urethral Candida
- The treatment of urethral candida typically involves the use of antifungal agents, with fluconazole being the preferred choice due to its ability to achieve high urine concentrations 3, 4.
- Removing predisposing factors, such as indwelling catheters and antibiotics, can help clear candiduria in almost 50% of asymptomatic patients 3.
- For symptomatic infections, fluconazole is the treatment of choice, while amphotericin B deoxycholate can be used as an alternative if fluconazole cannot be used due to resistance, allergy, or failure 4.
Antifungal Agents
- Fluconazole is a well-established first-line management option for the treatment and prophylaxis of localized and systemic Candida albicans infections, including those affecting the urinary tract 5.
- Itraconazole can be used as a second-line therapy for patients who do not respond to fluconazole, although it may be less well-tolerated 5.
- Other azole antifungals and echinocandins are not recommended for the treatment of urinary tract infections due to their inability to achieve adequate urine concentrations 3, 4.